Editas (EDIT) CEO Neil O'Neill Sells 5,124 Shares

What Happened

• Neil O'Neill, CEO and director of Editas Medicine (EDIT), sold 5,124 shares on 2026-09-03 in an open-market/private sale for a weighted-average price of $3.04 per share, totaling roughly $15,563. This was a sale (routine/cash-raising type transaction), not a purchase.

Key Details

• Transaction date: 2026-09-03; Form 4 filed: 2026-09-04 (timely filing).
• Price: weighted average $3.04; executed in multiple trades at prices ranging $3.0050–$3.0372.
• Shares disposed: 5,124; proceeds reported ≈ $15,563.
• Shares owned after transaction: not specified in the provided filing.
• Footnotes of note:
  • F1: Sale was effected under a durable automatic sales instruction plan adopted 4/13/2022 to satisfy tax-withholding on restricted stock units that vested 9/2/2026 — not a discretionary trade by the reporting person.
  • F2: Transaction executed in multiple trades; reporting person will provide detailed trade-by-trade quantities/prices to the SEC, issuer, or a security holder upon request.

Context

• This sale was to cover tax withholding related to RSU vesting, a common insider transaction that does not necessarily indicate a change in the insider’s view of the company. The use of an automatic sales instruction plan means the transaction was pre-arranged and non-discretionary.